Nuevo agente betalactámico en el manejo de la sepsis intra-abdominal

Rev. Gastroenterol. Perú 2003; 23 (3): 192-198

NUEVO AGENTE BETALACTÁMICO EN EL MANEJO DE LA SEPSIS INTRA-ABDOMINAL:
ESTUDIO DE FASE III, DOBLE CIEGO Y RANDOMIZADO DEL ERTAPENEM VS. PIPERACILINA/TAZOBACTAM

BIBLIOGRAFÍA

1. NICHOLS R. Intra-abdominal sepsis: Characterization and treatment. J. Inf. Dis. 1977;135:54.

2. BARBOZA E. Sepsis intra-abdominal. Tratado "Principios y Terapéutica Quirúrgica" 1ª. Edición 1999; 314-320.

3. BARTLETT JG, ONDERDONK AB, LOUIE T, et al : A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg 1978; 113:853-857.

4. GORBACH SL. Intra-abdominal infections. Clinical Infectious Diseases 1993; 17:961-967.

5. BARTLETT JG, MIAO PV, GORBACH SL. Empiric treatment with clindamycin and gentamicin of suspected sepsis due to anaerobic and aerobic bacteria. J Infect Dis 1977; 135(suppl):S80-5.

6. GUERRA JG. Selección de antibióticos en cirugía. Libro Principios y Terapéutica Quirúrgica de Barboza, 1ª. Edición, 1998; Cap II: 101-111.

7. SOLOMKIN JS, DELLINGER EP, CHRISTOU NV, et al. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg 1990;; 212:581-591.

8. BERNE TV, YELLIN AW, APPLEMAN MD, et al. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin versus cefamandole versus cefoperazone. Am J Surg 1982; 144:8-13.

9. BARBOZA E, CASTILLO M, YI A, GOTUZZO E. Clindamycin plus amikacin versus clindamycin plus aztreonam in established intra-abdominal infections. Surgery 1994; 116(1):28-35.

10. GOLDSTEIN EJ, CITRON DM, VRENI MC, et al. Comparative in vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections. Antimicrob Agents Chemother 2000; 44:2389-2394.

11. FUCHS PC, BARRY AL, BROWN SD. In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob Agents Chemother 2001; 45:1915-1918.

12. SOLOMKIN JS., YELLIN AE, ROTSTEIN OD, et al. Ertapenem versus Piperacillin/Tazobactam in the treatment of complicated intraabdominal infections. Ann. Surg 2003, 237L2) 235-245.

13. WEINSTEIN WM, ONDERDONK AB, BARTLETT JG, LOUIE TJ, GORBACH SL. Antimicrobial therapy of experimental intra-abdominal sepsis. J Infect Dis 1975; 132:282-6.

14. BARTLETT, JG. Pocket Book of Infectious Diseases Therapy. 8a. edition, Baltimore:Williams&Wilkins, 1997.

15. GORBACH SL. Antibiotic treatment of anaerobic infections. Clinical Infectious Diseases 1994; 18(suppl4):305-310.

16. BARBOZA E, CASTILLO M, PALOMINO J, GUERRA J. Intramusculary imipenem/cilastatin in the treatment of moderate infections requiring surgical treatment. Third European Congress Anaerobic Bacteria and Infections. Munich, March 8-10,1989.

17. BARBOZA E, CASTILLO M, YI A, PALOMINO J. Sepsis intra-abdominal. Estudio comparativo de tres grupos de antibióticos. Acta Med. Peruana 1984; XI(3):28-33.

18. MCCLEAN, KL, SHEEHAN GJ, HARDING GKM. Intra-abdominal infection: A review. Clinical Infectious Diseases 1994; 19:100-116.

19. GUERRA J, CASALINO E, PALOMINO J, BARBOZA E. Imipenen/cilastatin vs. Gentamycin/clindamycin for the treatment of moderate to severe infections in hospitalizad patients. Rev. Inf. Dis 1985; 7(3):S463-S470.

20. NICHOLS RL, MUZIK AC. Enterococcal infections in surgical patients: the mystery continues. Clin Infect Dis 1992; 15:72-76.

21. ALTEMEIER WA. The Bacterial flora of acute perforated appendicitis. Ann Surg 1938; 107:517.

22. BARBOZA E. Apendicitis aguda. Rev. Diagnóstico 1978; Vol 2:28.

23. ALTEMEIER WA, CULBERTSON WR, FULLEN WD, et al. Intra-abdominal abscesses. Am J Surg 1973;125:70-9.

24. ONDERDONK AB, BARTLETT JG, LOUIE TJ, SULLIVAN-SEIGLER N, GORBACH SL. Microbial synergy in experimental intra-abdominal abscess. Infect Immun 1976; 13:22-6.

25. HESELTINE PNR, YEELLIN AE, APPLEMAN MD, et al. Perforated and gangrenous appendicitis: an analysis of antibiotic failures. J Infect Dis 1983; 148:322-329.

26. SOLOMKIN JS, HEMSELL DL, SWEET R, et al. Evaluation of new anti-infective drugs for the treatment of intra-abdominal infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15 Suppl 1:S33-42.

27. BARBOZA E. Apendicitis aguda en la era de la Cirugía Laparoscópica. Editorial Rev. Gastroenterología del Perú; 2002: Vol 22 N°4.

28. WILSON SE, NORD CE. Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. European and North American experience. Am J Surg 1995; 169:21S-26S.

Regresar